Cancer Immunotherapy

Author:   David B. Teplow (Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA)
Publisher:   Elsevier Science Publishing Co Inc
ISBN:  

9780128165751


Pages:   354
Publication Date:   04 August 2019
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $451.44 Quantity:  
Add to Cart

Share |

Cancer Immunotherapy


Overview

Full Product Details

Author:   David B. Teplow (Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Weight:   0.700kg
ISBN:  

9780128165751


ISBN 10:   0128165758
Pages:   354
Publication Date:   04 August 2019
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. TNFR2 in cancer immunology and immunotherapy Xin Chen 2. From the Hellstrom paradox towards cancer cure Ingegerd Hellstrom and Karl Erik Hellstrom 3. CAR T-cell treatment of T-cell malignancy Martin Pule 4. Immunotherapy of pancreatic cancer Jorg Kleeff 5. Cancer stem cell immunology/immunotherapy Federica Cavallo 6. Cytokine release syndrome Alexander Shimabukuro-Vornhagen 7. Tumor Cell-Based Mechanisms of Resistance to Immune Attack Louis M. Weiner 8. Mushroom compounds in cancer immunotherapy Peter Amwoga Ayeka

Reviews

Author Information

David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

RGJ26

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List